M. Pacyna‐Gengelbach

发表

Diversity of gene expression in adenocarcinoma of the lung

D. Botstein, P. Brown, O. Troyanskaya, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer

John D. Minna, Tina Hernandez-Boussard, Jonathan R. Pollack, 2010 .

Patterns of chromosomal imbalances in invasive breast cancer

Karsten Schlüns, Iver Petersen, Janusz Szymas, 2000, International journal of cancer.

The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer.

M. Pacyna‐Gengelbach, I. Petersen, T. Knösel, 2012, Carcinogenesis.

Core classification of head and neck squamous cell carcinomas: correlations between morphology, DNA ploidy and HPV infection.

M. Pacyna‐Gengelbach, I. Petersen, M. Dietel, 2010, Pathology, research and practice.

Chromosomal Imbalances in Brain Metastases of Solid Tumors

S. Petersen, M. Pacyna‐Gengelbach, I. Petersen, 2000, Brain pathology.

Insulin‐like growth factor binding protein‐related protein 1 (IGFBP‐rP1) has potential tumour‐suppressive activity in human lung cancer

M. Pacyna‐Gengelbach, I. Petersen, K. Schlüns, 2007, The Journal of pathology.

Erratum: Diversity of gene expression in adenocarcinoma of the lung (Proceedings of the National Academy of Sciences of the United States of America (2001) 98 (13784-13789))

Russ B. Altman, David Botstein, Olga G. Troyanskaya, 2002 .

Characterization of γ-Aminobutyric Acid Type A Receptor–Associated Protein, a Novel Tumor Suppressor, Showing Reduced Expression in Breast Cancer

M. Pacyna‐Gengelbach, I. Petersen, S. Seitz, 2005, Cancer Research.

Reduced Expression in Breast Cancer Associated Protein , a Novel Tumor Suppressor , Showing −-Aminobutyric Acid Type A Receptor γ Characterization of Updated

M. Pacyna‐Gengelbach, I. Petersen, S. Seitz, 2005 .

Insulin-like growth factor binding protein-related protein 1 ( IGFBP-rP 1 ) has a potential tumor-suppressive activity in human lung cancer

M. Pacyna‐Gengelbach, I. Petersen, Yuan-Hua Chen, 2007 .

Identification of a Novel Homeobox-Containing Gene, LAGY, Which Is Downregulated in Lung Cancer

S. Petersen, M. Pacyna‐Gengelbach, I. Petersen, 2003, Oncology.

Chromosomal imbalances in wood dust‐related adenocarcinomas of the inner nose and their associations with pathological parameters

M. Pacyna‐Gengelbach, I. Petersen, M. Dietel, 2005, The Journal of pathology.

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

I Petersen, M. Pacyna‐Gengelbach, I. Petersen, 2008, Oncogene.

Gene expression profiles in human non-small and small-cell lung cancers.

M. Pacyna‐Gengelbach, I. Petersen, K. Schlüns, 2003, European journal of cancer.

Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesis

M. Pacyna‐Gengelbach, I. Petersen, K. Schlüns, 2003, International journal of cancer.

Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer

M. Pacyna‐Gengelbach, I. Petersen, S. Niesporek, 2007, International journal of cancer.

The Diagnostic Value of Cytokeratin 5/6, 14, 17, and 18 Expression in Human Non-Small Cell Lung Cancer

M. Pacyna‐Gengelbach, I. Petersen, M. Mireskandari, 2011, Oncology.

Antigenicity testing by immunohistochemistry after tissue oxidation

M. Pacyna‐Gengelbach, I. Petersen, M. Dietel, 2007, Journal of Clinical Pathology.

Molecular cytogenetic characterization of epithelioid hemangioendothelioma.

M. Pacyna‐Gengelbach, I. Petersen, T. Liehr, 2011, Cancer genetics.

Decreased PITX1 homeobox gene expression in human lung cancer.

M. Pacyna‐Gengelbach, I. Petersen, T. Knösel, 2007, Lung cancer.

5-Bromodeoxyuridine induced differentiation of a human small cell lung cancer cell line is associated with alteration of gene expression.

M. Pacyna‐Gengelbach, I. Petersen, Yuan-Hua Chen, 2007, Biochemical and biophysical research communications.

An Integrative Genetic, Epigenetic and Proteomic Characterization of Pancreatic Neuroendocrine Neoplasms (PanNENs) defines Distinct Molecular Features of α- and β-cell like Subgroups

M. Pacyna‐Gengelbach, U. Leser, D. Lenze, 2020 .

CGH Pattern of Esthesioneuroblastoma and their Metastases

M. Pacyna‐Gengelbach, I. Petersen, U. Bockmühl, 2004, Brain pathology.

Downregulation of connexin 26 in human lung cancer is related to promoter methylation

M. Pacyna‐Gengelbach, I. Petersen, T. Knösel, 2005, International journal of cancer.

Tumor suppression in mice lacking GABARAP, an Atg8/LC3 family member implicated in autophagy, is associated with alterations in cytokine secretion and cell death

R. König, M. Pacyna‐Gengelbach, I. Petersen, 2016, Cell Death and Disease.

Decreased expression of insulin-like growth factor binding protein 7 in human colorectal carcinoma is related to DNA methylation

M. Pacyna‐Gengelbach, I. Petersen, K. Schlüns, 2007, Journal of Cancer Research and Clinical Oncology.

Analysis of the RNA helicase A gene in human lung cancer.

Karsten Schlüns, Iver Petersen, Shujun Cheng, 2004, Oncology reports.

HOPX is methylated and exerts tumour‐suppressive function through Ras‐induced senescence in human lung cancer

M. Pacyna‐Gengelbach, I. Petersen, Yuan-Hua Chen, 2015, The Journal of pathology.

The Diagnostic Value of Cytokeratin 5/6, 14, 17, and 18 Expression in Human Non-Small Cell Lung Cancer

M. Pacyna‐Gengelbach, I. Petersen, M. Mireskandari, 2011, Oncology.

Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer.

M. Pacyna‐Gengelbach, I. Petersen, S. Seitz, 2005, Cancer research.

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer

M. Pacyna‐Gengelbach, I. Petersen, J. Pollack, 2009, Oncogene.